88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Accro Bioscience to Present Phase Ib Data of AC-101, an Oral Selective RIPK2 Inhibitor, for Moderate-to-Severe UC at UEG Week 2026 in Barcelona NEW YORK and SUZHOU, China , Aug. 13, 2026 /PRNewswire/ -- Accro Bioscience, a clinical-stage biotechnology company pioneering the development of novel therapeutics for immune mediated diseases, ... 2026-08-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nobel Heroes Day 2026 - AI For Science Summit (AFSS) Launches in Singapore This October Focusing on AI for Science: Nobel Laureates and Global Capital Explore the Frontiers of Scientific Innovation ... 2026-08-13T Biotechnology Computer/Electronics Education Health Care/Hospital
ArkBio Announces China IND Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis SHANGHAI , Aug. 13, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the Investigational New Drug (IND) application for AK0406 injection, the company's ... 2026-08-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Bringing K-Aesthetics to Australia: PharmaResearch Showcases REJURAN® at Aesthetics 2026 Following REJURAN ® 's TGA approval in 2023, the company hosted scientific sessions and a clinical masterclass for Australian healthcare professionals. ... 2026-08-13T Biotechnology Cosmetics & Personal Care Medical Equipment Medical/Pharmaceuticals
PanTRKare™ Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib) NANJING, China , Aug. 12, 2026 /PRNewswire/ -- August 6, the NMPA granted approval to Geneseeq's PanTRKare™ NTRK1/2/3 Gene Fusion Detection Kit as a companion diagnostic for VELMARTO ® ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks CAMBRIDGE, Mass. , Aug. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company , today ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Beyang Closes Oversubscribed $30 Million Series A Financing Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor ... 2026-08-12T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Beyang Closes Oversubscribed $30 Million Series A Financing Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Senhwa's CX-5461 Opens a New Frontier in Photoimmunotherapy; Multinational Study Published in Nucleic Acids Research TAIPEI and SAN DIEGO , Aug. 12, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. ( TPEx : 6492) today announced a significant research advance involving its investigational drug Pidnarulex (CX-5461). ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
BASF Agricultural Solutions invests in new Climate Center at its headquarters to strengthen research capabilities State-of-the-art research facility at Limburgerhof site responds to increasing regulatory and research demands Purpose-built facility will enable controlled, reproducible ecotoxicology studies to ... 2026-08-12T Agriculture Banking/Financial Service Biotechnology Chemical

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved